Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	941.48	1,105	1,274	1,506	193.46
Trading Asset Securities	100.01	75.52	0.12	3.97	-
Cash & Short-Term Investments	1,041	1,181	1,274	1,510	193.46
Cash Growth	-11.80%	-7.33%	-15.61%	680.49%	43.70%
Accounts Receivable	261.14	227.37	237.35	177.37	124.68
Other Receivables	15.17	15.39	10.66	16.79	9.89
Receivables	276.32	242.76	248.01	194.16	134.57
Inventory	962.01	760.22	699.43	521.86	476.55
Prepaid Expenses	-	4.19	5.61	2.47	0.04
Other Current Assets	25.02	20.7	33.92	16.19	13.1
Total Current Assets	2,305	2,209	2,261	2,245	817.71
Property, Plant & Equipment	153.02	166.88	97.32	75.45	60.04
Goodwill	7.56	-	-	-	-
Other Intangible Assets	4.93	3.95	0.6	0.21	0.44
Long-Term Deferred Tax Assets	23.91	14.74	18.36	3.88	2.97
Long-Term Deferred Charges	19.7	23.74	37.58	16.81	22.13
Other Long-Term Assets	2.86	-	-	18.25	2.84
Total Assets	2,517	2,418	2,415	2,359	906.13
Accounts Payable	202.46	216.32	179.57	167.37	206.07
Accrued Expenses	26.65	31.38	36.26	30.1	18.57
Short-Term Debt	0.34	30.18	0.23	9.61	0.07
Current Portion of Long-Term Debt	19.16	-	-	-	-
Current Portion of Leases	-	14.06	15.88	-	-
Current Income Taxes Payable	37.07	12.85	6.49	6.22	8.39
Current Unearned Revenue	48.31	36.69	29.07	20.52	14.68
Other Current Liabilities	7.84	4.28	7.47	15.25	1.78
Total Current Liabilities	341.82	345.76	274.97	249.07	249.56
Long-Term Debt	83.25	-	-	-	-
Long-Term Leases	38.33	37.95	41.19	31.21	27.71
Long-Term Deferred Tax Liabilities	7.94	7.2	8.06	2.77	-
Other Long-Term Liabilities	0.07	-	1.27	-	-
Total Liabilities	471.4	390.91	325.49	283.05	277.27
Common Stock	90.88	90.88	90.88	64.92	48.69
Additional Paid-In Capital	1,793	1,755	1,754	1,776	483.24
Retained Earnings	363.51	289.63	252.08	242.48	96.51
Treasury Stock	-199.98	-99.99	-	-	-
Comprehensive Income & Other	-1.63	-8.6	-6.96	-7.25	0.43
Shareholders' Equity	2,045	2,027	2,090	2,076	628.86
Total Liabilities & Equity	2,517	2,418	2,415	2,359	906.13
Total Debt	141.07	82.2	57.3	40.82	27.78
Net Cash (Debt)	900.41	1,099	1,217	1,469	165.68
Net Cash Growth	-18.04%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	10.27	12.35	13.44	19.93	2.47
Filing Date Shares Outstanding	84.64	88.33	90.88	90.88	68.16
Total Common Shares Outstanding	84.64	88.33	90.88	90.88	68.16
Working Capital	1,963	1,863	1,986	1,996	568.15
Book Value Per Share	24.17	22.95	22.99	22.84	9.23
Tangible Book Value	2,033	2,023	2,089	2,076	628.42
Tangible Book Value Per Share	24.02	22.91	22.98	22.84	9.22
Buildings	-	85.07	16.58	16.58	16.58
Machinery	-	45.93	47.23	35.62	21.9
Construction In Progress	-	15.41	-	5.1	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.